| Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment MH Steinberg, F Barton, O Castro, CH Pegelow, SK Ballas, A Kutlar, ... Jama 289 (13), 1645-1651, 2003 | 1161 | 2003 |
| Aberrant DNA methylation is a dominant mechanism in MDS progression to AML Y Jiang, A Dunbar, LP Gondek, S Mohan, M Rataul, C O'Keefe, ... Blood, The Journal of the American Society of Hematology 113 (6), 1315-1325, 2009 | 528 | 2009 |
| Inherited and somatic defects in DDX41 in myeloid neoplasms C Polprasert, I Schulze, MA Sekeres, H Makishima, B Przychodzen, ... Cancer cell 27 (5), 658-670, 2015 | 437 | 2015 |
| Dynamics of clonal evolution in myelodysplastic syndromes H Makishima, T Yoshizato, K Yoshida, MA Sekeres, T Radivoyevitch, ... Nature genetics 49 (2), 204-212, 2017 | 429 | 2017 |
| HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome Y Saunthararajah, R Nakamura, JM Nam, J Robyn, F Loberiza, ... Blood, The Journal of the American Society of Hematology 100 (5), 1570-1574, 2002 | 376 | 2002 |
| Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms F Traina, V Visconte, P Elson, A Tabarroki, AM Jankowska, E Hasrouni, ... Leukemia 28 (1), 78-87, 2014 | 364 | 2014 |
| Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease Y Saunthararajah, CA Hillery, D Lavelle, R Molokie, L Dorn, L Bressler, ... Blood 102 (12), 3865-3870, 2003 | 323 | 2003 |
| Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes JJ Molldrem, E Leifer, E Bahceci, Y Saunthararajah, M Rivera, C Dunbar, ... Annals of internal medicine 137 (3), 156-163, 2002 | 297 | 2002 |
| Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells J Wang, Y Saunthararajah, RL Redner, JM Liu Cancer research 59 (12), 2766-2769, 1999 | 286 | 1999 |
| Somatic SETBP1 mutations in myeloid malignancies H Makishima, K Yoshida, N Nguyen, B Przychodzen, M Sanada, Y Okuno, ... Nature genetics 45 (8), 942-946, 2013 | 281 | 2013 |
| Modification of hematopoietic stem cell fate by 5aza 2′ deoxycytidine and trichostatin A M Milhem, N Mahmud, D Lavelle, H Araki, J DeSimone, Y Saunthararajah, ... Blood 103 (11), 4102-4110, 2004 | 253 | 2004 |
| A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome Y Saunthararajah, R Nakamura, R Wesley, QJ Wang, AJ Barrett Blood 102 (8), 3025-3027, 2003 | 246 | 2003 |
| Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? J Barrett, Y Saunthararajah, J Molldrem Seminars in hematology 37 (1), 15-29, 2000 | 242 | 2000 |
| Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia KI Ataga, WR Smith, LM De Castro, P Swerdlow, Y Saunthararajah, ... Blood, The Journal of the American Society of Hematology 111 (8), 3991-3997, 2008 | 241 | 2008 |
| EVI1 induces myelodysplastic syndrome in mice S Buonamici, D Li, Y Chi, R Zhao, X Wang, L Brace, H Ni, ... The Journal of clinical investigation 114 (5), 713-719, 2004 | 234 | 2004 |
| Novel homo-and hemizygous mutations in EZH2 in myeloid malignancies H Makishima, AM Jankowska, RV Tiu, H Szpurka, Y Sugimoto, Z Hu, ... Leukemia 24 (10), 1799-1804, 2010 | 221 | 2010 |
| SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes V Visconte, HJ Rogers, J Singh, J Barnard, M Bupathi, F Traina, ... Blood, The Journal of the American Society of Hematology 120 (16), 3173-3186, 2012 | 218 | 2012 |
| Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome JP Maciejewski, D Follmann, R Nakamura, Y Saunthararajah, CE Rivera, ... Blood, The Journal of the American Society of Hematology 98 (13), 3513-3519, 2001 | 204 | 2001 |
| Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease DJ Wilkie, R Molokie, D Boyd-Seal, ML Suarez, YO Kim, S Zong, H Wittert, ... Journal of the National Medical Association 102 (1), 18-27, 2010 | 179 | 2010 |
| Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies SN Khan, AM Jankowska, R Mahfouz, AJ Dunbar, Y Sugimoto, N Hosono, ... Leukemia 27 (6), 1301-1309, 2013 | 165 | 2013 |
